Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women

被引：0
|
作者：
Lees, M
Graham-Clarke, P
Davey, P
Thiebaud, D
Price, N
Grainger, D
机构：
[1] M TAG Pty Ltd, Sydney, NSW, Australia
[2] Eli Lilly Australia Pty Ltd, Hlth Outcomes Dept, Sydney, NSW, Australia
[3] Eli Lilly Australia & Corp, Sydney, NSW, Australia
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of teriparatide (Forteo) in the prevention of osteoporotic fractures among men and postmenopausal women in Australia
    Graham-Clarke, PL
    Lees, M
    Wolthers, T
    Thiebaud, D
    Price, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 297 - 297
  • [2] Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Christensen, PM
    Brixen, K
    Gyrd-Hansen, D
    Kristiansen, IS
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (05) : 387 - 396
  • [3] Prevention of osteoporotic fractures in Dutch men and women: A cost effectiveness evaluation
    De Laet, CE
    Pols, HAP
    [J]. BONE, 2001, 28 (05) : S93 - S93
  • [4] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    [J]. VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [5] Cost-effectiveness of raloxifene for the prevention of osteoporotic fractures in Australia
    Davey, PJ
    Lees, M
    Graham-Clarke, P
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 224 - 224
  • [6] The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
    Stevenson, M.
    Davis, S.
    Lloyd-Jones, M.
    Beverley, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (04) : 1 - +
  • [7] COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE VS. TERIPARATIDE FOR THE PREVENTION OF OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Silverman, S.
    Weiss, R.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S314 - S314
  • [8] A cost-effectiveness model of tibolone as treatment for the prevention of osteoporotic fractures in postmenopausal women in Sweden
    Willis, M
    Ödegaard, K
    Persson, U
    Hedbrant, J
    Mellström, D
    Hammar, M
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 115 - 127
  • [9] A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden
    Michael Willis
    Knut Ödegaard
    Ulf Persson
    Johan Hedbrant
    Dan Mellström
    Mats Hammar
    [J]. Clinical Drug Investigation, 2001, 21 : 115 - 127
  • [10] COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S55
12345